Mario Alberto Accardi insider trades

Open-market stock purchases and sales by Mario Alberto Accardi, Chief Executive Officer at Centessa Pharmaceuticals plc, from SEC Form 4 filings since Jun 24, 2025.

Recent trades

DateStockTradeValue
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)—
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$59.6K
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$161K
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$58.9K
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$240K
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$3.8M
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$6.9M
May 1, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$23.8K
Feb 2, 2026CNTA Centessa Pharmaceuticals plcBought (not open market)—
Feb 2, 2026CNTA Centessa Pharmaceuticals plcBought (not open market)—
Feb 1, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$71.6K
Dec 9, 2025CNTA Centessa Pharmaceuticals plcSold$213K
Dec 9, 2025CNTA Centessa Pharmaceuticals plcSold$75K
Dec 8, 2025CNTA Centessa Pharmaceuticals plcSold$300K
Dec 8, 2025CNTA Centessa Pharmaceuticals plcBought (not open market)—
Nov 1, 2025CNTA Centessa Pharmaceuticals plcSold (not open market)$14.8K
Oct 27, 2025CNTA Centessa Pharmaceuticals plcSold$200K
Oct 27, 2025CNTA Centessa Pharmaceuticals plcBought (not open market)—

Companies traded

  • CNTA Centessa Pharmaceuticals plc: 9 sales, last Jun 24, 2026

Get free alerts when Mario Alberto Accardi files a new trade →